After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...

OpenAI's rebrand balances the technical and the emotional by updating its logo and centering a new typeface called OpenAI ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...

While some information has been restored, scientists are still alarmed over the removal of data. It's not clear what has ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic disea ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Noga Barpal from PxE Imaging and Linda Reschke from Basler discuss how AI and 3D imaging are transforming industrial vision in this Visionaries webcast.